A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids
Abstract Globally, colorectal cancer (CRC) is the third most frequently occurring cancer. Progression on to an advanced metastatic malignancy (metCRC) is often indicative of poor prognosis, as the 5-year survival rates of patients decline rapidly. Despite the availability of many systemic therapies...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Nature Portfolio
2024-02-01
|
| 丛编: | npj Precision Oncology |
| 在线阅读: | https://doi.org/10.1038/s41698-024-00543-8 |